AI Science Tracker
EN

Koç University Research Center for Translational Medicine (KUTTAM)

1 discovery from 2024

Discoveries

Artificial intelligence assisted patient blood and urine droplet pattern analysis for non-invasive and accurate diagnosis of bladder cancer

Source check: Source checked. Not independent scientific confirmation.

Finding: publisher text verifies ResNet-18 analysis of patient/control blood and urine droplet images with diagnostic discrimination metrics; no evidence of clinical utility or external validation.

Technology: ResNet-18 image classifier

Publication: Peer-reviewed paper · Test context: prospective or independent check. Catalog categories, not an evidence grade.

AI contribution
Uses ResNet-18 to classify patient and control blood/urine droplet images against the study diagnostic labels.
Test and result
The paper evaluated ResNet-18 discrimination between patient and control blood/urine droplet images using the reported diagnostic labels; no external validation or clinical-utility evaluation is claimed.
Limitation / still unknown
The image-classification result does not establish external validation or clinical utility.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/article/MED/38291121 · https://www.nature.com/articles/s41598-024-52728-7

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 4/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.